Nicholas Reder

Nicholas Reder has a diverse work experience in the field of biosciences, pathology, and engineering. Nicholas currently serves as the Chief Executive Officer of Alpenglow Biosciences, Inc., a position they have held since February 2019. Prior to this role, they were the Chief Scientific Officer of the same company from August 2018 to February 2019.

Nicholas'sinvolvement in the College of American Pathologists (CAP) includes being a member of the Digital and Computational Pathology Committee since October 2020, where they also chair the AWE Subcommittee. Nicholas was previously the Chair of the Awareness and Education Subcommittee and a Full Member of the In Vivo Microscopy Committee from January 2019 to September 2020. Nicholas started their involvement with CAP as a Junior Member of the In Vivo Microscopy Committee from January 2017 to December 2018.

Additionally, Nicholas Reder has worked at the University of Washington, where they held the position of Acting Instructor since July 2018. Nicholas also served as a Pathology Resident and Genitourinary Pathology Fellow from July 2014 to June 2018.

Furthermore, they gained research experience at the University of Washington College of Engineering as a Research Fellow in the Dr. Jonathan Liu Biophotonics Lab from July 2016 to June 2017.

Nicholas Reder has a diverse education history. Nicholas first attended the University of Michigan from 2004 to 2008, where they obtained a Bachelor of Science degree in Biochemistry. Following this, they pursued further education at Emory University from 2008 to 2010, earning a Master of Public Health degree with a focus on Epidemiology. Lastly, from 2010 to 2014, Nicholas attended Loyola University Chicago Stritch School of Medicine, where they obtained their Doctor of Medicine (MD) degree.